Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 18.89
(1.23%)
CNY 18.89
(1.23%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 128.76 Million CNY | -50.17% |
| 2022 | 258.43 Million CNY | -9.19% |
| 2021 | 284.59 Million CNY | 141.73% |
| 2020 | 117.73 Million CNY | 200.67% |
| 2019 | 39.15 Million CNY | 98.93% |
| 2018 | 19.68 Million CNY | 32.42% |
| 2017 | 14.86 Million CNY | 62.93% |
| 2016 | 9.12 Million CNY | 2.31% |
| 2015 | 8.91 Million CNY | 10.62% |
| 2014 | 8.06 Million CNY | 29.46% |
| 2013 | 6.22 Million CNY | 315.95% |
| 2012 | 1.49 Million CNY | 568.67% |
| 2011 | 223.88 Thousand CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 120.51 Million CNY | -2.42% |
| 2024 Q1 | 125.42 Million CNY | -2.59% |
| 2024 Q2 | 123.5 Million CNY | -1.54% |
| 2023 Q2 | 123.82 Million CNY | -45.12% |
| 2023 FY | 128.76 Million CNY | -50.17% |
| 2023 Q1 | 225.61 Million CNY | -12.7% |
| 2023 Q4 | 128.76 Million CNY | 22.87% |
| 2023 Q3 | 104.79 Million CNY | -15.37% |
| 2022 FY | 258.43 Million CNY | -9.19% |
| 2022 Q4 | 258.43 Million CNY | -44.61% |
| 2022 Q3 | 466.54 Million CNY | -22.44% |
| 2022 Q2 | 601.5 Million CNY | 41.78% |
| 2022 Q1 | 424.26 Million CNY | 49.08% |
| 2021 FY | 284.59 Million CNY | 141.73% |
| 2021 Q4 | 284.59 Million CNY | 42.2% |
| 2021 Q3 | 200.13 Million CNY | 0.61% |
| 2021 Q1 | 210.04 Million CNY | 78.41% |
| 2021 Q2 | 198.91 Million CNY | -5.3% |
| 2020 Q3 | 120.85 Million CNY | 55.37% |
| 2020 FY | 117.73 Million CNY | 200.67% |
| 2020 Q1 | 43.78 Million CNY | 11.83% |
| 2020 Q2 | 77.78 Million CNY | 77.64% |
| 2020 Q4 | 117.73 Million CNY | -2.59% |
| 2019 Q1 | 21.16 Million CNY | 7.52% |
| 2019 Q2 | 29.01 Million CNY | 37.09% |
| 2019 Q4 | 39.15 Million CNY | 6.84% |
| 2019 Q3 | 36.65 Million CNY | 26.33% |
| 2019 FY | 39.15 Million CNY | 98.93% |
| 2018 Q3 | 20.19 Million CNY | 25.42% |
| 2018 Q1 | 15.16 Million CNY | 2.0% |
| 2018 Q2 | 16.09 Million CNY | 6.18% |
| 2018 FY | 19.68 Million CNY | 32.42% |
| 2018 Q4 | 19.68 Million CNY | -2.52% |
| 2017 Q4 | 14.86 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 12.38 Million CNY | 0.0% |
| 2017 FY | 14.86 Million CNY | 62.93% |
| 2016 Q4 | 9.12 Million CNY | 0.0% |
| 2016 FY | 9.12 Million CNY | 2.31% |
| 2016 Q3 | 9.12 Million CNY | -13.55% |
| 2016 Q2 | 10.55 Million CNY | 0.0% |
| 2016 Q1 | 10.55 Million CNY | 18.35% |
| 2015 Q3 | 8.91 Million CNY | 6.74% |
| 2015 Q2 | 8.35 Million CNY | 0.0% |
| 2015 Q4 | 8.91 Million CNY | 0.0% |
| 2015 FY | 8.91 Million CNY | 10.62% |
| 2015 Q1 | 8.35 Million CNY | 3.64% |
| 2014 Q2 | 8.18 Million CNY | 0.0% |
| 2014 FY | 8.06 Million CNY | 29.46% |
| 2014 Q3 | 8.06 Million CNY | -1.52% |
| 2014 Q1 | 8.18 Million CNY | 31.45% |
| 2014 Q4 | 8.06 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q3 | 6.22 Million CNY | 0.0% |
| 2013 Q4 | 6.22 Million CNY | 0.0% |
| 2013 FY | 6.22 Million CNY | 315.95% |
| 2012 FY | 1.49 Million CNY | 568.67% |
| 2011 FY | 223.88 Thousand CNY | 0.0% |